Détail de l'auteur
Auteur Patthey-Vuadens O |
Documents disponibles écrits par cet auteur (9)
trié(s) par (Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de recherche
Article
Dorchies OM ; Reutenauer-Patte J ; Dahmane E ; Ismail HM ; Petermann O ; Patthey-Vuadens O ; Comyn SA ; Gayi E ; Piacenza T ; Handa RJ ; Décosterd LA ; Ruegg UT | 02/2013Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Dorchies O ; Gallo C ; Reutenauer-Patte J ; Ismail HM ; Gayi E ; Petermann O ; Patthey-Vuadens O | 2011Duchenne muscular dystrophy (DMD) is a fatal muscle disorder caused by the absence of dystrophin and characterized by progressive muscle wasting. Oxidative stress and excessive calcium influx are thought to contribute to the pathogenesis. Indeed[...]Article
Hibaoui Y ; Reutenauer-Patte J ; Patthey-Vuadens O ; Dorchies OM | 2011Accès au résumé PubMed / to PubMed abstractArticle
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Dorchies O ; Reutenauer-Patte J ; Montet X ; Patthey-Vuadens O ; Ruegg U | 2011DMD is a fatal muscle disorder caused by the absence of dystrophin and characterized by progressive muscle wasting. Weakness of the back muscles often causes postural alterations, impairing patients' respiratory function. Oxidative stress likely[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Dorchies O ; Reutenauer-Patte J ; Petermann O ; Patthey-Vuadens O ; Gayi E ; Ruegg U | 2011To date, no cure exists for Duchenne muscular dystrophy, a fatal muscle disorder. Recently, we evaluated tamoxifen (TAM), a selective estrogen receptor modulator (SERM), used to treat certain breast cancers, on the mdx5Cv dystrophic mouse. We fo[...]Article
Reutenauer J ; Dorchies OM ; Patthey-Vuadens O ; Vuagniaux G | 2008Accès au résumé PubMed / to PubMed abstractArticle
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Reutenauer J ; Dorchies O ; Boittin FX ; Patthey-Vuadens O | 2008Urocortins are structurally related peptides of the corticotrophin-releasing factor (CRF), which has been widely implicated in responses to physical, emotional and environmental stress. Recently, it has been reported that a CRF-receptor-2 (CRFR2[...]Article
Colloque jeunes chercheurs (7 mars 2008; EVRY - Centre conférence Génocentre Evry) ; Reutenauer J ; Dorchies O ; Boittin FX ; Patthey-Vuadens O ; Ruegg U | 2008Urocortins are structurally related peptides of the corticotrophin-releasing factor (CRF), which has been widely implicated in responses to physical, emotional and environmental stress. Recently, it has been reported that a CRF-receptor-2 (CRFR2[...]